Chronic Obstructive Pulmonary Disease Flashcards

1
Q

What process is hindered in Chronic Obstructive Pulmonary Disease? What values are affected? What happens to Total Lung Capacity (TLC)?

A

Airway obstruction. Lung does not empty and air is trapped. FVC is lowered, FEV1 is lowered even more, results in a decrease in FEV1:FVC ratio. Total lung capacity is usually increased due to air trapping.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the presentation of chronic bronchitis? What is it associated with? What is seen on histology? What measurement scale is used to assess the damage of the disease?

A

Chronic productive cough lasting at least 3 months over a minimum of 2 years. Highly associated with smoking. Hypertrophy of bronchial mucinous glands. Reid index (thickness of mucus glands relative to bronchial wall thickness) which increases to > 50% (normal is 40%).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the clinical features of chronic bronchitis?

A
  1. Productive cough due to excessive mucus production
  2. Cyanosis (‘blue bloaters’) - Mucus plugs trap CO2 which increases PaCO2 and decreases PaO2. 3. Increased risk of infection and cor pumonale
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is emphysema?

A

Destruction of alveolar air sacs. Loss of elastic recoil and collapse of airways during exhalation results in obstruction and air trapping.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What structures are involved in emphysema?

A

Destruction of alveolar air sacs. Loss of elastic recoil and collapse of airways during exhalation results in obstruction and air trapping.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What process is disrupted in emphysema? What happens?

A

Imbalance of proteases and antiproteases. Inflammation in the lung normally leads to release of proteases by neutrophils and macrophages. alpha1-antitrypsin (A1AT) neutralizes proteases. Excessive inflammation or lack of A1AT leads to destruction of the alveolar air sacs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What process is disrupted in emphysema? What happens?

A

Imbalance of proteases and antiproteases. Inflammation in the lung normally leads to release of proteases by neutrophils and macrophages. alpha1-antitrypsin (A1AT) neutralizes proteases. Excessive inflammation or lack of A1AT leads to destruction of the alveolar air sacs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the most common cause of emphysema? What does it cause and which part of the lungs does it affect?

A

Smoking. Pollutants in smoke lead to excessive inflammation and protease-mediated damage. Results in CENTRIACINAR emphysema that is most severe in the upper lobes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does alpha1-antitrypsin (A1AT) deficiency lead to ? What does it cause and which part of the lungs does it affect? What other organ is affected?

A

Lack of antiprotease leaves the air sacs vulnerable to protease-mediated damage. Results in PANACINAR emphysema that is most severe in the lower lobes. Liver cirrhosis may also be present.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is the liver damaged in alpha1-antitrypsin (A1AT)? What is seen on biopsy?

A

A1AT deficiency is due to misfolding of the mutated protein. Mutant A1AT accumulates in the endoplasmic reticulum of hepatocytes, resulting in liver damage. Biopsy reveals pink, PAS-positive globules in hepatocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the normal allele in A1AT (alpha1-antitrypsin) deficiency? How many copies are expressed?

A

PiM. 2 copies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the most common clinically relevant mutation in A1AT (alpha1-antitrypsin) deficiency?

A

PiZ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which mutations are usually asymptomatic with decreasing levels of A1AT (alpha1-antitrypsin)? How is the risk level increased for emphysema?

A

PiMZ heterozygotes. When Smoking is present.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which mutations are at significant risk for panacinar emphysema and cirrhosos?

A

PiZZ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which mutations are at significant risk for panacinar emphysema and cirrhosis?

A

PiZZ homozygotes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 5 clinical features of emphysema?

A
  1. Dyspnea and cough with minimal sputum 2. Prolonged expiration with pursed lips (‘pink puffer’) 3. Weight loss 4. Increased anterior-posterior diameter of chest 5. Hypoxemia and cor pulmonale
17
Q

What is asthma? What causes it and when does it present?

A

Reversible airway bronchoconstriction, most often due to allergic stimuli (atopic asthma). Presents in childhood, often associated with allergic rhinitis, eczema and a family history of atopy.

18
Q

What is the pathogenesis of Asthma? What type of hypersensitivity is it?

A

Type I.

  1. Allergens induce TH2 phenotype in CD4+ T cells of genetically susceptible individuals.
  2. TH2 cells secrete IL-4 (mediates class switch to IgE), IL-5 (attracts eosinophils) and IL-10 (stimulates TH2 cells and inhibits TH1).
  3. Reexposure to allergen leads to IgE mediated activation of mast cells.
19
Q

How is the damage done via IgE mediated activation of mast cells in asthma?

A
  1. Release of preformed histamine granules and 1. generation of leuktrienes C4, D4, and E4 lead to bronchoconstriction, inflammation and edema (early-phase reaction)
  2. Inflammation, especially major basic protein derived from eosinophils, damages cells and perpetuates bronchoconstriction (late phase reaction).
20
Q

How is the damage done via IgE mediated activation of mast cells in asthma?

A
  1. Release of preformed histamine granules and 1. generation of leuktrienes C4, D4, and E4 lead to bronchoconstriction, inflammation and edema (early-phase reaction)
  2. Inflammation, especially major basic protein derived from eosinophils, damages cells and perpetuates bronchoconstriction (late phase reaction).
21
Q

What is the pattern of the clinical features of asthma? What is it related to? What are the three features?

A

Episodic and related to allergen exposure.

  1. Dyspnea and wheezing
  2. Productive cough, clasically with spiral-shaped mucus plugs (Curschmann spirals) and eosinophil-derived crystals (Charcot-Leyden crystals)
  3. Severe unrelenting attack can lead to status asthmaticus and death
22
Q

What are non allergenic causes of asthma?

A

Exercise, viral infection, aspirin (aspirin intolerant asthma) and occupational exposures.

23
Q

What are non allergenic causes of asthma?

A

Exercise, viral infection, aspirin (aspirin intolerant asthma) and occupational exposures.

24
Q

A patient comes in with cough, dyspnea and foul smelling sputum. What does he have? What are some complications?

A

He has Bronchiectasis which is a permanent dilatation of bronchioles and bronchi. Loss of airway tone results in air trapping. Complications include hypoxemia with cor pulmonale and secondary AA amyloidosis

25
Q

What are the 5 causes of bronchiectasis?

A

1, Cystic fibrosis 2. Karatagener syndrome 3. Tumor or foreign body 4. Necrotizing infection 5. Allergic bronchopulmonary aspergillosis

26
Q

What is Kartagener syndrome and what diseases is it associated with?

A

Inherited defect of the dyenin arm which is necessary for ciliary movement. Associated with sinusitis, infertility, situs inversus.

27
Q

What two diseases is allergic bronchopulmonary aspergillosis usually seen?

A

Asthmatics and Cystic Fibrosis